Vermox: Uses, Dosage & Side Effects
An anthelmintic (anti-worm) medication containing mebendazole, used to treat pinworm (threadworm) infections in adults and children aged 2 years and older
Vermox (mebendazole) is a widely used anthelmintic medication available as an oral suspension for the treatment of pinworm (threadworm, Enterobius vermicularis) infections. It belongs to the benzimidazole class of antiparasitic drugs and works by disrupting the worm’s ability to absorb glucose, ultimately leading to energy depletion and death of the parasite. Vermox is listed on the WHO Model List of Essential Medicines and is available over-the-counter in many countries for pinworm treatment. It is approved for adults and children aged 2 years and older. A single 5 ml dose is typically effective, with a repeat dose recommended after 2 weeks to prevent reinfection from hatching eggs.
Quick Facts: Vermox
Key Takeaways
- Vermox (mebendazole) is a well-established anthelmintic medication that treats pinworm infections by blocking the parasite’s glucose absorption, leading to its death within days of treatment.
- A single 5 ml dose of oral suspension is the standard treatment for pinworm; a repeat dose after approximately 2 weeks is essential to eliminate newly hatched worms from surviving eggs.
- All household members should be treated simultaneously to prevent the cycle of reinfection, as pinworm eggs are highly contagious and spread easily through contaminated surfaces.
- Vermox should not be given to children under 1 year of age due to reports of seizures in infants; it is approved for use in children aged 2 and older, with use in 1–2 year-olds only on medical advice.
- Metronidazole must not be taken concurrently with Vermox due to a suspected link with serious skin reactions including Stevens-Johnson syndrome and toxic epidermal necrolysis.
What Is Vermox and What Is It Used For?
Vermox contains the active substance mebendazole, a broad-spectrum benzimidazole anthelmintic that has been used worldwide since the 1970s for the treatment of intestinal worm infections. Mebendazole is included on the World Health Organization (WHO) Model List of Essential Medicines, recognizing its importance as a safe and effective treatment for helminth infections. In its over-the-counter formulation, Vermox oral suspension is primarily indicated for the treatment of pinworm (Enterobius vermicularis) infections in adults and children aged 2 years and older.
Pinworm infection (enterobiasis) is one of the most common parasitic infections worldwide, particularly prevalent among school-age children. The WHO estimates that approximately 200 million people globally are infected with pinworms at any given time, with the highest prevalence in temperate regions. The infection occurs when pinworm eggs are ingested, typically through contaminated hands, food, or household surfaces. Once ingested, the eggs hatch in the small intestine, and the larvae migrate to the large intestine where they mature into adult worms over approximately 2–6 weeks. Female pinworms then migrate to the perianal area at night to deposit thousands of eggs, causing the characteristic intense itching (pruritus ani) that is the hallmark symptom of the infection.
The mechanism of action of mebendazole is well characterized. The drug selectively and irreversibly binds to β-tubulin in the intestinal cells of helminths, inhibiting the polymerization of tubulin into microtubules. Microtubules are essential cellular structures required for nutrient transport, cell division, and maintenance of cell shape. By disrupting the microtubule network, mebendazole blocks glucose uptake by the parasite, depleting its glycogen stores and impairing its energy metabolism. This process leads to immobilization and eventual death of the worm, typically within 1–3 days after treatment. Importantly, mebendazole also inhibits the development and hatching of worm eggs, although eggs that have already been deposited in the environment remain viable and infectious.
Because mebendazole acts locally within the gastrointestinal tract and has very low systemic absorption (approximately 5–10% of an oral dose), it achieves high concentrations at the site of infection while maintaining a favorable safety profile with minimal systemic side effects. This pharmacokinetic property makes it particularly suitable for use as an over-the-counter medication for uncomplicated pinworm infections.
Mebendazole at higher doses and longer treatment durations can also be used to treat other intestinal helminth infections, including roundworm (Ascaris lumbricoides), whipworm (Trichuris trichiura), and hookworm (Ancylostoma duodenale and Necator americanus). However, these indications typically require medical prescription and supervision, and the over-the-counter Vermox oral suspension is specifically indicated and dosed for pinworm treatment only.
To prevent the cycle of reinfection, it is strongly recommended that all household members are treated simultaneously, even those without symptoms. Pinworm eggs are microscopic and can survive on surfaces, clothing, and bedding for up to 2–3 weeks. Asymptomatic carriers are common and can continuously reinfect treated individuals. Combining medication with thorough hygiene measures provides the best chance of complete eradication.
What Should You Know Before Taking Vermox?
Contraindications
The primary contraindication for Vermox is known hypersensitivity (allergy) to mebendazole or any of the excipients in the formulation. If you have previously experienced an allergic reaction to mebendazole or any benzimidazole anthelmintic, you should not take Vermox. Signs of an allergic reaction may include skin rash, itching, swelling of the face or throat, or difficulty breathing.
Vermox oral suspension contains sucrose as an excipient. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase insufficiency should not take this medicine. The suspension also contains the preservatives propyl parahydroxybenzoate (E216) and methyl parahydroxybenzoate (E218), which may cause allergic reactions (possibly delayed) in some individuals. The sodium content is negligible (less than 1 mmol per 5 ml dose), meaning the product is essentially sodium-free.
Warnings and Precautions
Vermox must not be used in children under 1 year of age. Seizures (convulsions) have been reported in infants treated with mebendazole, including very young infants. For children between 1 and 2 years of age, Vermox should only be given if a doctor has specifically prescribed it. Children aged 2 years and older can use Vermox at the standard dose.
While Vermox is generally well tolerated, certain precautions should be observed. In rare cases, seizures and dizziness have been reported during treatment. Patients should be aware of this possibility, particularly when driving or operating machinery. If you experience dizziness or other neurological symptoms during treatment, you should refrain from activities that require alertness until the symptoms resolve.
Patients with liver disease should use mebendazole with caution and ideally under medical supervision, as the drug undergoes hepatic metabolism. Although systemic absorption is low at the single-dose pinworm treatment regimen, prolonged or higher-dose treatments may increase hepatic exposure. Cases of hepatitis and liver function abnormalities have been reported, primarily with longer treatment courses used for other helminth infections.
Pregnancy and Breastfeeding
Pregnant women should only use Vermox after consultation with and prescription by a doctor. The experience with mebendazole use during human pregnancy is limited. Although animal reproduction studies have shown teratogenic effects at high doses, the clinical significance for humans at the low doses used for pinworm treatment is unclear. The European Medicines Agency and the WHO note that the benefit-risk balance should be carefully evaluated in each individual case during pregnancy.
Mebendazole may pass into breast milk, although in very small amounts given its low systemic absorption. Breastfeeding mothers should consult a healthcare provider before using Vermox. The short treatment duration (single dose with one repeat) and low bioavailability suggest that the risk to a nursing infant is likely minimal, but professional guidance is recommended.
If you are pregnant, think you may be pregnant, or are planning to become pregnant, always seek medical advice before taking any medication, including over-the-counter products like Vermox.
How Does Vermox Interact with Other Drugs?
Although mebendazole has low systemic absorption, certain drug interactions have been identified that are clinically important. The most significant interaction is with metronidazole, an antibiotic commonly used to treat bacterial and protozoal infections. Concurrent use of mebendazole and metronidazole is contraindicated because of a suspected association with severe and potentially life-threatening skin reactions, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These are rare but extremely serious conditions in which the skin and mucous membranes develop widespread blistering and peeling, requiring hospitalization and intensive care.
The exact mechanism behind this interaction is not fully understood, but it is hypothesized that the combination may trigger an immune-mediated hypersensitivity reaction in susceptible individuals. Both drugs individually have been associated with rare skin reactions, and their combined use appears to amplify this risk significantly. Patients who require both antiparasitic and antibacterial/antiprotozoal treatment should discuss alternative medications with their healthcare provider.
Cimetidine, a histamine H2-receptor antagonist used for the treatment of peptic ulcers and gastroesophageal reflux disease, has been shown to inhibit the hepatic metabolism of mebendazole. This can lead to increased blood levels of mebendazole when the two drugs are taken together. While this interaction is unlikely to be clinically significant at the single low dose used for pinworm treatment, patients taking cimetidine should inform their doctor or pharmacist before using Vermox, particularly if higher or prolonged doses of mebendazole are prescribed for other helminth infections.
There are no significant interactions between mebendazole and common over-the-counter medications such as paracetamol (acetaminophen), ibuprofen, or antihistamines. However, as with any medication, it is good practice to inform your healthcare provider or pharmacist about all prescription and non-prescription medicines, herbal products, and dietary supplements you are currently taking.
| Interacting Drug | Severity | Effect | Recommendation |
|---|---|---|---|
| Metronidazole | Major | Suspected increased risk of Stevens-Johnson syndrome and toxic epidermal necrolysis | Do not use concurrently. Choose alternative antibiotic/antiparasitic therapy. |
| Cimetidine | Moderate | Inhibits hepatic metabolism of mebendazole, potentially increasing blood levels | Consult your doctor. Monitor for increased side effects if using higher mebendazole doses. |
Even though Vermox is available without a prescription, it is important to tell your pharmacist about all other medications you are taking. Drug interactions can occur even with over-the-counter products. If you are unsure whether it is safe to take Vermox with your current medications, ask a healthcare professional for advice.
What Is the Correct Dosage of Vermox?
The dosing of Vermox for pinworm (threadworm) infection is straightforward and the same for all age groups from 2 years onward. The oral suspension should be shaken well before each use to ensure uniform distribution of the active ingredient. The dose should be measured using the calibrated dosing cup provided with the product. The bottle has a child-resistant cap that is opened by pressing down and turning counterclockwise.
Adults
Adult Dosage — Pinworm
Dose: 5 ml (100 mg mebendazole) oral suspension as a single dose.
Repeat: Take a second 5 ml dose after approximately 2 weeks.
The repeat dose is essential because the first treatment kills the adult worms but does not destroy all eggs. Pinworm eggs that were deposited before treatment can hatch within 2 weeks and establish a new infection. The second dose eliminates these newly hatched worms before they can mature and lay new eggs, thereby breaking the infection cycle.
Children
Children Aged 2 Years and Older
Dose: 5 ml (100 mg mebendazole) oral suspension as a single dose — same as adults.
Repeat: Take a second 5 ml dose after approximately 2 weeks.
The oral suspension formulation with banana flavor is particularly suitable for children who may have difficulty swallowing tablets.
Children Aged 1–2 Years
Only on medical prescription. Vermox should only be given to children in this age group if a doctor has specifically ordered it.
The dosage for this age group should be determined by the prescribing physician based on the individual clinical assessment.
Children Under 1 Year
Do not use. Vermox must not be given to infants under 1 year of age. Seizures have been reported in this age group.
Elderly Patients
No dose adjustment is required for elderly patients. The standard pinworm dosage of 5 ml as a single dose, repeated after 2 weeks, applies. Elderly patients with significant liver impairment should consult a healthcare provider before use, as mebendazole undergoes hepatic metabolism.
Missed Dose
Because Vermox for pinworm is taken as a single dose with one planned repeat after 2 weeks, the concept of a “missed dose” is somewhat different from daily medications. If you forget to take the repeat dose at the 2-week mark, take it as soon as you remember. Do not take a double dose to make up for a forgotten dose. If symptoms persist or return after completing both doses, consult a healthcare provider for further evaluation.
Overdose
If you or a child has accidentally taken more Vermox than recommended, contact a healthcare provider, hospital emergency department, or poison control center immediately for assessment and advice. Symptoms of overdose may include abdominal cramps, nausea, vomiting, and diarrhea. Due to the low systemic absorption of mebendazole at standard doses, serious systemic toxicity from a single accidental overdose is unlikely, but medical evaluation is still recommended.
| Age Group | Single Dose | Repeat Dose | Notes |
|---|---|---|---|
| Adults | 5 ml (100 mg) | 5 ml after 2 weeks | Standard OTC dosage |
| Children ≥ 2 years | 5 ml (100 mg) | 5 ml after 2 weeks | Same as adult dose |
| Children 1–2 years | As prescribed | As prescribed | Prescription only; medical supervision required |
| Children < 1 year | Do not use | Do not use | Contraindicated; risk of seizures |
Medication alone is not sufficient to eliminate a pinworm infection. Strict hygiene practices must be followed for at least 2–6 weeks to prevent reinfection. Key measures include: washing the anal area daily with soap and water; frequent handwashing, especially before meals and after using the toilet; keeping fingernails short and clean; sleeping in close-fitting undergarments or pajamas and changing them daily; washing bedding frequently; laundering worn clothing on the same day it is changed; daily cleaning of bathroom surfaces and toilet seats; and washing household pets (dogs and cats), as pinworm eggs can be present in their fur even though animals themselves are not infected by human pinworms.
What Are the Side Effects of Vermox?
Like all medicines, Vermox can cause side effects, although not everybody gets them. The overall safety profile of mebendazole is well established after decades of worldwide use. At the low single dose used for pinworm treatment, side effects are generally mild and transient. The frequency and severity of side effects tend to increase with higher doses and longer treatment courses used for other helminth infections.
It is important to understand the frequency categories used in describing side effects. “Common” means the effect occurs in up to 1 in 10 users; “uncommon” means up to 1 in 100; “rare” means up to 1 in 1,000; and “very rare” means up to 1 in 10,000 users. The side effects listed below have been reported during clinical trials and post-marketing surveillance.
Stop taking Vermox and contact your doctor immediately or go to the nearest emergency department if you experience any of the following rare symptoms of angioedema: swelling of the face, tongue, or throat; difficulty swallowing; hives (urticaria) with breathing difficulties. Also seek immediate help for severe skin reactions such as widespread rash with or without blisters, skin redness, mouth or genital sores (Stevens-Johnson syndrome), or large areas of skin peeling (toxic epidermal necrolysis). These are life-threatening emergencies.
Common
May affect up to 1 in 10 users
- Abdominal pain (stomach pain)
Uncommon
May affect up to 1 in 100 users
- Abdominal discomfort
- Diarrhea
- Flatulence (excess gas)
Rare
May affect up to 1 in 1,000 users
- Decreased white blood cell count (neutropenia)
- Hypersensitivity reactions, including anaphylactic reactions (with fever, skin rash, swelling, and sometimes low blood pressure)
- Seizures (convulsions)
- Dizziness
- Hepatitis (inflammation of the liver)
- Abnormal liver function tests
- Skin rash
- Skin redness (erythema)
- Hives (urticaria)
- Hair loss (alopecia)
Very Rare
May affect up to 1 in 10,000 users
- Nausea
- Vomiting
Serious Skin Reactions
Very serious but extremely rare skin reactions have been reported with mebendazole use, including Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). These conditions involve widespread blistering and peeling of the skin and mucous membranes, often accompanied by fever and flu-like symptoms. They are medical emergencies requiring immediate hospitalization. The risk appears to be higher when mebendazole is used concurrently with metronidazole, which is why this combination is contraindicated.
Seizures in Children
Seizures (convulsions) have been reported in children treated with mebendazole, including in infants. This is the primary reason why Vermox is contraindicated in children under 1 year of age and should only be used in children aged 1–2 years under direct medical supervision. In older children and adults, seizures remain a rare adverse event. If seizures occur during treatment, medical attention should be sought immediately.
Reporting Side Effects
If you experience any side effects, whether listed above or not, it is important to report them to your healthcare provider. Reporting suspected adverse reactions after a medicine has been authorized helps ongoing monitoring of its benefit-risk balance. In the United States, adverse events can be reported to the FDA MedWatch program. In the European Union, reports can be made through the national pharmacovigilance systems of each member state. In the United Kingdom, the Yellow Card Scheme administered by the MHRA accepts reports from both healthcare professionals and patients.
How Should You Store Vermox?
Vermox oral suspension does not require any special storage conditions. It should be stored at room temperature (typically below 25°C or 77°F) and protected from direct sunlight and excessive heat. There is no need for refrigeration. The bottle should be kept tightly closed when not in use to protect the contents from contamination.
As with all medicines, Vermox must be kept out of the sight and reach of children. The bottle is equipped with a child-resistant cap as an additional safety measure, but this should not replace proper storage in a secure location. Do not use Vermox after the expiration date (marked as “EXP”) printed on the packaging. The expiration date refers to the last day of the indicated month.
Do not dispose of unused medicine by flushing it down the toilet or throwing it in household waste. Return any unused or expired medication to your pharmacy for proper disposal. These measures help protect the environment and prevent accidental exposure.
What Does Vermox Contain?
The active ingredient in Vermox oral suspension is mebendazole at a concentration of 20 mg per ml. Each 5 ml dose therefore contains 100 mg of mebendazole.
Inactive Ingredients (Excipients)
The other ingredients in Vermox oral suspension serve various pharmaceutical functions:
- Sucrose – sweetener to improve palatability
- Microcrystalline cellulose and carmellose sodium – suspending agents that keep the mebendazole particles uniformly distributed
- Methylcellulose – thickening and stabilizing agent
- Methyl parahydroxybenzoate (E218) – preservative (may cause allergic reactions, possibly delayed)
- Sodium lauryl sulfate – wetting agent to aid dispersion of the active ingredient
- Propyl parahydroxybenzoate (E216) – preservative (may cause allergic reactions, possibly delayed)
- Banana flavoring – for improved taste, particularly for children
- Citric acid monohydrate – pH buffer to maintain product stability
- Purified water – vehicle
Product Appearance
Vermox oral suspension is a milky-white, banana-flavored liquid supplied in a 30 ml bottle with a child-resistant cap. Each package includes a calibrated dosing cup for accurate dose measurement. The dosing cup may be a 5 ml cup with markings at 2.5 ml and 5 ml, or a 10 ml cup with markings at 5 ml and 10 ml. Always check the markings on your specific dosing cup carefully before measuring the dose. One dose corresponds to 5 ml.
Frequently Asked Questions About Vermox
Vermox begins working immediately after ingestion. The mebendazole in the suspension acts locally in the gut, disrupting the worms’ ability to absorb glucose. The adult pinworms typically die and are expelled in the stool within 1–3 days. However, itching may persist for a few more days as the perianal area heals. The crucial repeat dose after 2 weeks targets any worms that hatch from eggs deposited before the first treatment.
Yes, it is strongly recommended that all household members are treated at the same time, regardless of whether they have symptoms. Pinworm eggs are microscopic and extremely contagious, spreading through contaminated hands, surfaces, bedding, and clothing. Many infected individuals, particularly adults, are asymptomatic carriers who can continuously reinfect others. Treating only the symptomatic person frequently leads to a cycle of reinfection within the household.
In many countries, Vermox oral suspension for pinworm treatment is available over-the-counter (without a prescription) from pharmacies. However, availability and regulatory status vary by country. In some regions, mebendazole requires a prescription for all indications. When used for helminth infections other than pinworm (such as roundworm, whipworm, or hookworm), higher doses and longer courses are needed, and these typically require a prescription and medical supervision. Your pharmacist can advise you on the availability in your country.
The repeat dose after approximately 2 weeks is critical for successful treatment. The first dose of Vermox kills the adult pinworms in the intestine, but it does not destroy all pinworm eggs that have already been deposited on perianal skin, underwear, bedding, and environmental surfaces. These eggs remain viable for 2–3 weeks and can be re-ingested, leading to a new infection. The second dose is timed to coincide with when any surviving eggs would have hatched and the larvae would have grown into young worms, eliminating them before they can mature and lay new eggs.
Vermox is approved and considered safe for children aged 2 years and older at the standard 5 ml dose. The banana-flavored oral suspension is specifically designed to be palatable for children. Vermox should not be given to children under 1 year because seizures have been reported in infants. For children between 1 and 2 years, it should only be used if prescribed by a doctor. If your child is 2 or older and has pinworms, Vermox is a well-established and effective treatment with a good safety profile at the recommended dose.
Good hygiene is essential alongside medication to prevent reinfection. Key measures include: washing your hands thoroughly and frequently, especially before meals and after using the toilet; keeping fingernails short and avoiding nail-biting; washing the perianal area each morning with soap and water; showering rather than bathing to reduce egg spread; sleeping in close-fitting underwear or pajamas and changing them daily; changing and washing bed linens frequently; laundering clothing on the day it is worn; cleaning bathroom floors, toilet seats, and sinks daily; and washing household pets, as pinworm eggs can cling to their fur even though animals are not infected by human pinworms.
References
- World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. Geneva: WHO; 2023.
- World Health Organization (WHO). Guideline: Preventive Chemotherapy to Control Soil-Transmitted Helminth Infections in At-Risk Population Groups. Geneva: WHO; 2017.
- European Medicines Agency (EMA). Mebendazole – Summary of Product Characteristics. Last updated 2025. Available from: EMA.
- U.S. Food and Drug Administration (FDA). Mebendazole Drug Label. Revised 2024. Available from: FDA Drug Label.
- British National Formulary (BNF). Mebendazole. NICE Evidence Services. 2025. Available from: BNF.
- Bethony J, Brooker S, Albonico M, et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet. 2006;367(9521):1521–1532. doi:10.1016/S0140-6736(06)68653-4.
- Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008;299(16):1937–1948. doi:10.1001/jama.299.16.1937.
- Wendt S, Trawinski H, Schughart G, et al. Pinworm (Enterobius vermicularis) infection – a comprehensive review. Eur J Clin Microbiol Infect Dis. 2019;38(2):209–218. doi:10.1007/s10096-018-3389-6.
- Chai JY, Jung BK, Hong SJ. Albendazole and mebendazole as anti-parasitic and anti-cancer agents: an update. Korean J Parasitol. 2021;59(3):189–225. doi:10.3347/kjp.2021.59.3.189.
- Lacey E. Mode of action of benzimidazoles. Parasitol Today. 1990;6(4):112–115. doi:10.1016/0169-4758(90)90227-U.
Editorial Team
This article was written and reviewed by the iMedic Medical Editorial Team, comprising licensed specialist physicians with expertise in infectious diseases, parasitology, and clinical pharmacology.
Medical Content
iMedic Infectious Diseases Editorial Team – specialist physicians with clinical experience in parasitic infections and anthelmintic therapy
Medical Review
iMedic Medical Review Board – independent panel verifying accuracy against WHO guidelines, EMA SmPC, FDA label, and BNF
Pharmacology Review
iMedic Clinical Pharmacology Team – specialists in drug interactions, pharmacokinetics, and medication safety
Accessibility & SEO
iMedic Digital Health Team – ensuring WCAG 2.2 AAA compliance and optimal search visibility
All content follows the GRADE evidence framework and is reviewed according to international medical guidelines. iMedic receives no commercial funding from pharmaceutical companies.